Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Pernix Therapeutics Holdings, Inc.

NASDAQ: PTXHealthcare / Drug Manufacturers - Other / USA
0.350000.00Vol 262 4221Y Perf -85.63%
Dec 13th, 2018 10:04
BID0.3300 ASK0.3400
Open0.3600 Previous Close0.3500
Pre-Market0.36 After-Trading0.36
 0.01 2.86%  0.01 2.86%
Target Price
3.00 
Analyst Rating
— 0.00
Potencial %
837.50 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     43.37
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)5 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.64 
Earnings Date
8th Nov 2018

Today's Price Range

0.31000.3600

 

52wk Range

0.27003.30

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Month
-41.67%
3 Months
-63.16%
6 Months
-85.42%
1 Year
-85.63%
3 Years
-98.65%
5 Years
-98.57%

Quotes

Name / TickerPriceChg.Chg.%
PTX0.35000.00000.00
AAPL171.592.49001.47
GOOG1 073.039.35000.88
MSFT110.311.23001.13
XOM76.550.53000.70
WFC47.54-0.2000-0.42
JNJ148.251.15000.78
FB145.050.55000.38
GE7.400.690010.28
JPM101.210.19000.19
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.80
Current Ratio
1.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-2.00
Leverage Ratio -1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
68.80
EBIT Margin
-16.00
EBITDA Margin
9.10
Pre-tax Profit Margin
-69.60
Profit Margin
-67.40
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.79
PS Ratios
0.04
Price to Cash Flow
35.40
Price to Free Cash Flow
-0.10
Cash Flow Per Share
-1.81
Price to Tangible Book
-0.02
Book Value per Share
-14.12
Enterprise Value (in ths.)
303 432
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-696.24
ROE last 12 Months
43.88
Return on Assets (5Y Avg)
-35.32
ROA last 12 Months
-29.58
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.20
Receivables Turnover
1.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
127 398
Revenue per Share
8.78
Revenue Growth 3 Years
-8.81
Revenue Growth 5 Years
8.92
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--2.78-
Q04 2016--3.86-
Q03 2016--2.73-
Q02 2016-0.50-4.90-880.00
Q01 20160.00-3.50-
Q04 2015-0.20-5.90-2 850.00
Q03 20150.100.80700.00
Q02 2015-0.10-1.00-900.00
Earnings Per EndEstimateRevision %Trend
12/2016 FY-3.700.00-
12/2017 FY0.100.00-
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume262 422
Shares Outstanding (in ths.)14 510
Trades Count187
Dollar Volume88 394
Avg. Volume215 289
Avg. Weekly Volume1 751 288
Avg. Monthly Volume1 142 147
Avg. Quarterly Volume491 283

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

89%11%

Bearish Bullish

81%19%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News